Passive Monitoring nQ Medical offers passive, 24/7 digital health monitoring for neurodegenerative disorders by analyzing user interactions with common devices, presenting a compelling opportunity to expand into remote patient monitoring contracts and real-world data studies.

Clinical Trial Support The company already provides remote recruitment and real-world data collection to support disease detection and staging, suggesting upsell potential for large pharma, contract research organizations, and academic trials seeking faster enrollment and unbiased at-home observation.

PD Management Platform The Mobile PD Management Platform enables outpatient therapy measurement, clinical titration, and adherence tools, offering a turnkey solution for drug-device combinations and caregiver engagement—a strong fit for neurology pharmacovigilance and post-market surveillance deals.

Strategic Partnerships Recent collaborations with Fleksy and the Davis Phinney Foundation demonstrate market validation and access to patient communities, which can be leveraged to accelerate pilot programs, broaden sponsor networks, and foster co development opportunities.

Growth & Scale Potential With a small team, modest revenue, and ongoing funding, nQ Medical can be positioned for scalable pilots with mid to large biotech and device companies seeking AI powered neurodegeneration insights, remote monitoring, and passive data collection to differentiate offerings.